Literature DB >> 4040349

Timing of combined hyperthermia and 1,3-bis(2-chloroethyl)-1-nitrosourea or cis-diamminedichloroplatinum in BD IX rats with BT4A tumours.

O Mella, O Dahl.   

Abstract

Groups of 7-10 evaluable BD IX rats with the neurogenic BT4A tumour on the right hind leg were treated with waterbath hyperthermia (44 degrees C, 60 min) in combination with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) 20 mg/kg or cis-diamminedichloroplatinum (cis-DDP) 3 mg/kg i.p. at different sequences and timing within +/- 24 hr. Tumour responses were evaluated by tumour doubling time and clinical criteria, toxicity by toxic deaths, weight loss, and local skin reactions. With both BCNU and cis-DDP, tumour response was markedly dependent on timing; the greatest effects were obtained giving hyperthermia just after the drug. Local side effects were not different in the timing groups, but cis-DDP general toxicity was most severe when cis-DDP was given just before hyperthermia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040349

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Influence of hyperthermia on efficacy and uptake of carbon nanohorn-cisplatin conjugates.

Authors:  Matthew R DeWitt; Allison M Pekkanen; John Robertson; Christopher G Rylander; Marissa Nichole Rylander
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

2.  Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells.

Authors:  S Ohno; Z H Siddik; Y Kido; L A Zwelling; J M Bull
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line.

Authors:  E Kimura; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.